Thermo Fisher Scientific Stock

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:01 2024-04-26 pm EDT 5-day change 1st Jan Change
573.6 USD +0.33% Intraday chart for Thermo Fisher Scientific +4.60% +8.07%
Sales 2024 * 43.06B Sales 2025 * 46.13B Capitalization 218B
Net income 2024 * 6.32B Net income 2025 * 7.17B EV / Sales 2024 * 5.59 x
Net Debt 2024 * 22.65B Net Debt 2025 * 18.95B EV / Sales 2025 * 5.14 x
P/E ratio 2024 *
35.1 x
P/E ratio 2025 *
30.2 x
Employees 122,000
Yield 2024 *
0.26%
Yield 2025 *
0.28%
Free-Float 87.14%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.33%
1 week+4.60%
Current month-1.31%
1 month-1.00%
3 months+2.84%
6 months+32.96%
Current year+8.07%
More quotes
1 week
543.15
Extreme 543.15
586.46
1 month
529.64
Extreme 529.64
589.93
Current year
527.32
Extreme 527.32
603.82
1 year
415.60
Extreme 415.6
603.82
3 years
415.60
Extreme 415.6
672.34
5 years
250.21
Extreme 250.21
672.34
10 years
107.33
Extreme 107.33
672.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 01-10-31
Director of Finance/CFO 57 01-05-31
Chief Tech/Sci/R&D Officer - 18-12-31
Members of the board TitleAgeSince
Chief Executive Officer 55 01-10-31
Director/Board Member 67 12-03-29
Director/Board Member 62 22-02-28
More insiders
Date Price Change Volume
24-04-26 573.6 +0.33% 1,437,128
24-04-25 571.7 -0.98% 1,184,004
24-04-24 577.4 +0.49% 2,035,044
24-04-23 574.6 +4.78% 2,543,991
24-04-22 548.4 +0.66% 1,522,884

Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT

More quotes
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
571.7 USD
Average target price
618.2 USD
Spread / Average Target
+8.13%
Consensus